March 28th 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
Biologics for RA treatment don't increase cancer risk
October 4th 2012Biologic response modifiers developed for the treatment of rheumatoid arthritis do not appear to be associated with an increased risk of cancer, according to a study published September 5 in the Journal of the American Medical Association.
Acellular pertussis vaccine may not provide long-lasting immunity
October 2nd 2012The acellular pertussis vaccine that was introduced in the 1990s may not offer long-lasting protection against whooping cough in immunized children after the fifth dose, according to a case-control study published September 13 in the New England Journal of Medicine.
Methamphetamine, heroin users have similar risk for dental disease
October 2nd 2012Long-term users of methamphetamine compared with heroin users in an urban setting had a high prevalence of dental disease, much higher than the general U.S. population, according to a small cross-sectional study published September 1 in the Journal of the American Dental Association.
New guidelines: Screen adults for hypertriglyceridemia every 5 years
September 20th 2012An Endocrine Society task force has established new clinical-practice guidelines that recommend screening adults for high triglyceride levels. Find out the reason behind the new recommendations and how often the screening should be administered.
tPA: Still the underused clot-buster in stroke management
September 15th 2012Patients suffering stroke often do not seek immediate help. Just as disturbing, lack of stroke expertise in many hospitals and skepticism among ER physicians may prevent tPA from being administered to the patients who need it most.